Literature DB >> 18495771

Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2.

Jason Netland1, David K Meyerholz, Steven Moore, Martin Cassell, Stanley Perlman.   

Abstract

Infection of humans with the severe acute respiratory syndrome coronavirus (SARS-CoV) results in substantial morbidity and mortality, with death resulting primarily from respiratory failure. While the lungs are the major site of infection, the brain is also infected in some patients. Brain infection may result in long-term neurological sequelae, but little is known about the pathogenesis of SARS-CoV in this organ. We previously showed that the brain was a major target organ for infection in mice that are transgenic for the SARS-CoV receptor (human angiotensin-converting enzyme 2). Herein, we use these mice to show that virus enters the brain primarily via the olfactory bulb, and infection results in rapid, transneuronal spread to connected areas of the brain. This extensive neuronal infection is the main cause of death because intracranial inoculation with low doses of virus results in a uniformly lethal disease even though little infection is detected in the lungs. Death of the animal likely results from dysfunction and/or death of infected neurons, especially those located in cardiorespiratory centers in the medulla. Remarkably, the virus induces minimal cellular infiltration in the brain. Our results show that neurons are a highly susceptible target for SARS-CoV and that only the absence of the host cell receptor prevents severe murine brain disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18495771      PMCID: PMC2493326          DOI: 10.1128/JVI.00737-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  56 in total

1.  Chemokines are produced in the brain early during the course of experimental African trypanosomiasis.

Authors:  A Sharafeldin; R Eltayeb; M Pashenkov; M Bakhiet
Journal:  J Neuroimmunol       Date:  2000-03-01       Impact factor: 3.478

2.  Susceptibility of murine CNS to OC43 infection.

Authors:  H Jacomy; P J Talbot
Journal:  Adv Exp Med Biol       Date:  2001       Impact factor: 2.622

Review 3.  Immune function of astrocytes.

Authors:  Y Dong; E N Benveniste
Journal:  Glia       Date:  2001-11       Impact factor: 7.452

Review 4.  Immune function of microglia.

Authors:  F Aloisi
Journal:  Glia       Date:  2001-11       Impact factor: 7.452

5.  Severe acute respiratory syndrome coronavirus fails to activate cytokine-mediated innate immune responses in cultured human monocyte-derived dendritic cells.

Authors:  Thedi Ziegler; Sampsa Matikainen; Esa Rönkkö; Pamela Osterlund; Maarit Sillanpää; Jukka Sirén; Riku Fagerlund; Milla Immonen; Krister Melén; Ilkka Julkunen
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

6.  Neuroinvasion by human respiratory coronaviruses.

Authors:  N Arbour; R Day; J Newcombe; P J Talbot
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

7.  Toxoplasma gondii infection of neurons induces neuronal cytokine and chemokine production, but gamma interferon- and tumor necrosis factor-stimulated neurons fail to inhibit the invasion and growth of T. gondii.

Authors:  D Schlüter; M Deckert; H Hof; K Frei
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

Review 8.  Cytokines and acute neurodegeneration.

Authors:  S M Allan; N J Rothwell
Journal:  Nat Rev Neurosci       Date:  2001-10       Impact factor: 34.870

9.  Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells.

Authors:  Helen K W Law; Chung Yan Cheung; Hoi Yee Ng; Sin Fun Sia; Yuk On Chan; Winsie Luk; John M Nicholls; J S Malik Peiris; Yu Lung Lau
Journal:  Blood       Date:  2005-04-28       Impact factor: 22.113

Review 10.  Immunopathogenesis of coronavirus infections: implications for SARS.

Authors:  Stanley Perlman; Ajai A Dandekar
Journal:  Nat Rev Immunol       Date:  2005-12       Impact factor: 53.106

View more
  513 in total

Review 1.  Coronavirus Disease 2019 (COVID-19) From the Point of View of Neurologists: Observation of Neurological Findings and Symptoms During the Combat Against a Pandemic.

Authors:  Ayşe Nur Özdağ Acarli; Bedia Samanci; Esme Ekizoğlu; Arman Çakar; Nermin Görkem Şirin; Tuncay Gündüz; Yeşim Parman; Betül Baykan
Journal:  Noro Psikiyatr Ars       Date:  2020-05-01       Impact factor: 1.339

2.  Neurovascular Complications in COVID-19 Infection: Case Series.

Authors:  A M Franceschi; R Arora; R Wilson; L Giliberto; R B Libman; M Castillo
Journal:  AJNR Am J Neuroradiol       Date:  2020-06-11       Impact factor: 3.825

3.  Association of Guillain-Barre Syndrome With COVID-19: A Case Report and Literature Review.

Authors:  Romil Singh; Saher T Shiza; Rabeea Saadat; Manal Dawe; Usama Rehman
Journal:  Cureus       Date:  2021-03-11

Review 4.  Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review.

Authors:  Adeel S Zubair; Lindsay S McAlpine; Tova Gardin; Shelli Farhadian; Deena E Kuruvilla; Serena Spudich
Journal:  JAMA Neurol       Date:  2020-08-01       Impact factor: 18.302

5.  Differential virological and immunological outcome of severe acute respiratory syndrome coronavirus infection in susceptible and resistant transgenic mice expressing human angiotensin-converting enzyme 2.

Authors:  Naoko Yoshikawa; Tomoki Yoshikawa; Terence Hill; Cheng Huang; Douglas M Watts; Shinji Makino; Gregg Milligan; Tehsheng Chan; Clarence J Peters; Chien-Te K Tseng
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

6.  Anosmia and dysgeusia associated with SARS-CoV-2 infection: an age-matched case-control study.

Authors:  Alex Carignan; Louis Valiquette; Cynthia Grenier; Jean Berchmans Musonera; Delphin Nkengurutse; Anaïs Marcil-Héguy; Kim Vettese; Dominique Marcoux; Corinne Valiquette; Wei Ting Xiong; Pierre-Hughes Fortier; Mélissa Généreux; Jacques Pépin
Journal:  CMAJ       Date:  2020-05-27       Impact factor: 8.262

Review 7.  SARS-CoV-2 and nervous system: From pathogenesis to clinical manifestation.

Authors:  Kiandokht Keyhanian; Raffaella Pizzolato Umeton; Babak Mohit; Vahid Davoudi; Fatemeh Hajighasemi; Mehdi Ghasemi
Journal:  J Neuroimmunol       Date:  2020-11-07       Impact factor: 3.478

8.  Immunization with an attenuated severe acute respiratory syndrome coronavirus deleted in E protein protects against lethal respiratory disease.

Authors:  Jason Netland; Marta L DeDiego; Jincun Zhao; Craig Fett; Enrique Álvarez; José L Nieto-Torres; Luis Enjuanes; Stanley Perlman
Journal:  Virology       Date:  2010-01-27       Impact factor: 3.616

Review 9.  Coronaviruses post-SARS: update on replication and pathogenesis.

Authors:  Stanley Perlman; Jason Netland
Journal:  Nat Rev Microbiol       Date:  2009-06       Impact factor: 60.633

10.  Coronavirus immunoreactivity in individuals with a recent onset of psychotic symptoms.

Authors:  Emily G Severance; Faith B Dickerson; Raphael P Viscidi; Ioannis Bossis; Cassie R Stallings; Andrea E Origoni; Anne Sullens; Robert H Yolken
Journal:  Schizophr Bull       Date:  2009-06-02       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.